Course overview
COVID-19 and Cardiovascular Impact
In this course, faculty educate you on the implications of viral infections and bacterial infections in general, emphasizing how the COVID-19 virus encompasses all of the impacts of these different types of organisms in one virus.
Faculty
Douglas Harrington, MD
Conference Series
AIHM 2020 Annual Conference
Required Lessons
1
Time to Complete
45 minutes
Non-CME Eligible*
0 Credits
What you will learn
-
Course Summary
-
By the end of this course, learners will be able to:
- Explain the role of infections with cardiovascular diseases.
- Identify risk factors that induce endothelial injury and inflammation.
- Discuss the clinical challenges surrounding cardiac diseases and the role of COVID-19.
Course includes:
Included in this course
Course Faculty
Douglas Harrington, MD
About Douglas
Dr. Douglas Harrington has over 30 years of experience in the research, development, commercialization, and expansion of innovative healthcare technology and services. As former President and Lab Director of Nichols Institute, Dr. Harrington expanded their molecular genetics, infectious disease, immunology, cytogenetic, and anatomic pathology offerings.
Dr. Harrington holds a number of patents including automated image analysis of residual cancer protein, catalytic heavy metal extraction, and biomarker assays for diagnosis and classification of cardiac disease. He has been involved as director or founder of multiple startup companies – from devices to molecular genetics focusing on immunology, cancer and cardiology, where he has taken a number of new molecular technologies through state and federal regulatory approval.
Dr. Harrington holds a number of patents including automated image analysis of residual cancer protein, catalytic heavy metal extraction, and biomarker assays for diagnosis and classification of cardiac disease. He has been involved as director or founder of multiple startup companies – from devices to molecular genetics focusing on immunology, cancer and cardiology, where he has taken a number of new molecular technologies through state and federal regulatory approval.
*CME/CEU Credits
This course is not eligible for CME/CEU credits.